US2009263783A1PendingUtilityA1
Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
Assignee: INST NAT L DE LA SANTE ET DE LPriority: Jun 23, 1998Filed: Dec 17, 2008Published: Oct 22, 2009
Est. expiryJun 23, 2018(expired)· nominal 20-yr term from priority
A61P 37/06A61P 25/00C07K 14/005C12Q 1/702G01N 33/56983A61K 38/00C07K 14/4713A61P 21/00C12N 2740/10022
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a translational product encoded by the nucleotide sequence of SEQ ID NO: 2, which corresponds to the gag gene of an endogenous human retrovirus named HERV-7q. The present invention also provides methods for diagnosing a neurological or autoimmune disease in a patient.
Claims
exact text as granted — not AI-modified1 . A translational product encoded by the nucleotide sequence of SEQ ID NO: 2, corresponding to the gag gene of an endogenous human retrovirus named HERV-7q.
2 . The translational product according to claim 1 , which is selected from the group consisting of the sequences SEQ ID NOs: 29 to 34, 36, and 58.
3 . A method for diagnosing a neurological or autoimmune disease in a patient, comprising the detection of a translation product according to claim 1 in a biological sample containing proteins obtained from said patient.
4 . The method according to claim 3 , wherein said neurological or autoimmune disease is multiple sclerosis.
5 . The method according to claim 3 , wherein said detection is an immunodetection.
6 . A method for diagnosing a neurological or autoimmune disease in a patient, comprising comparative analysis of the expression of the translational product according to claim 1 between a biological sample containing proteins obtained from said patient and a sample from a normal individual used as a reference.
7 . The method according to claim 6 , wherein said neurological or autoimmune disease is multiple sclerosis.
8 . A method for diagnosing a neurological or autoimmune disease in a patient, comprising comparing the protein sequences present in a biological sample from said patient with the sequence of the translation product according to claim 1 .
9 . The method according to claim 8 , wherein said neurological or autoimmune disease is multiple sclerosis.Join the waitlist — get patent alerts
Track US2009263783A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.